Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.
Identifieur interne : 000248 ( PubMed/Corpus ); précédent : 000247; suivant : 000249Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.
Auteurs : Hai-Bin Wei ; Jian Zhuo ; Xiao-Wen Sun ; Kun Pang ; Yi Shao ; Sheng-Jie Liang ; Di Cui ; Fu-Jun Zhao ; Jun-Jie Yu ; Shu-Jie XiaSource :
- Lasers in medical science [ 1435-604X ] ; 2014.
English descriptors
- KwdEn :
- Aged, Follow-Up Studies, Humans, Laser Therapy (adverse effects), Laser Therapy (methods), Lasers, Male, Postoperative Complications (etiology), Postoperative Period, Preoperative Care, Prospective Studies, Prostate (pathology), Prostate (surgery), Prostatectomy (adverse effects), Prostatic Hyperplasia (physiopathology), Prostatic Hyperplasia (surgery), Thulium (therapeutic use), Treatment Outcome, Urination.
- MESH :
- chemical , therapeutic use : Thulium.
- adverse effects : Laser Therapy, Prostatectomy.
- etiology : Postoperative Complications.
- methods : Laser Therapy.
- pathology : Prostate.
- physiopathology : Prostatic Hyperplasia.
- surgery : Prostate, Prostatic Hyperplasia.
- Aged, Follow-Up Studies, Humans, Lasers, Male, Postoperative Period, Preoperative Care, Prospective Studies, Treatment Outcome, Urination.
Abstract
Thulium laser resection of the prostate-tangerine technique (TmLRP-TT) dissects whole prostatic lobes off the surgical capsule, similar to peeling a tangerine. The present study aimed to evaluate the safety and efficacy of TmLRP-TT for older symptomatic benign prostatic hyperplasia patients with large prostates during 18 months of follow-up. A prospective analysis of 95 consecutive patients with large prostates (>80 ml) who underwent surgical treatment using TmLRP-TT was carried out. All patients were evaluated preoperatively and at 1, 6, 12, and 18 months postoperatively by the International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urinary flow rate (Q max), postvoid residual urine volume (PVR), International Index of Erectile Function 5 (IIEF-5), urine analysis, and urine culture. Perioperative complications were recorded and graded by the modified Clavien classification system (CCS). Mean preoperative prostate volume was 106.81 ± 24.79 ml. TmLRP-TT was successfully completed in all patients. The mean operative duration, catheterization time, and hospital stay were 95.36 ± 27.06 min, 2.25 ± 0.9 days, and 5.39 ± 1.18 days, respectively. The decrease in mean hemoglobin level was 1.23 ± 0.72 g/dl, and that in mean serum sodium level was 0.71 ± 2.56 mmol/l. Within the observation period of 18 months, the patients showed an improvement in IPSS (20.01 ± 7.08 vs. 4.96 ± 3.68), QoL (4.10 ± 1.16 vs. 1.23 ± 1.30), Q max (8.14 ± 3.81 ml/s vs. 18.33 ± 2.56 ml/s) and PVR (102.70 ± 70.64 ml vs. 20.28 ± 30.02 ml), compared with baseline values (P < 0.001). IIEF-5 remained stable. Minor complications occurred in 10 (10.52 %) of 95 patients (Clavien grade 1, 9.47 % and grade 2, 1.05 %). There were no severe complications requiring reintervention (Clavien grade 3, 0 % and grade 4, 0 %). TmLRP-TT is a safe and effective surgical endoscopic technique associated with a low complication rate in large prostates as assessed during an 18-month follow-up period. It is a promising technology, which may be considered as one of the alternatives to open simple prostatectomy (OP) for large prostates in the future.
DOI: 10.1007/s10103-013-1437-8
PubMed: 24026112
Links to Exploration step
pubmed:24026112Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.</title><author><name sortKey="Wei, Hai Bin" sort="Wei, Hai Bin" uniqKey="Wei H" first="Hai-Bin" last="Wei">Hai-Bin Wei</name><affiliation><nlm:affiliation>Department of Urology, Shanghai First People's Hospital Affiliated to Shanghai Jiaotong University, No.100, Haining Road, Hongkou District, Shanghai, 200080, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhuo, Jian" sort="Zhuo, Jian" uniqKey="Zhuo J" first="Jian" last="Zhuo">Jian Zhuo</name></author><author><name sortKey="Sun, Xiao Wen" sort="Sun, Xiao Wen" uniqKey="Sun X" first="Xiao-Wen" last="Sun">Xiao-Wen Sun</name></author><author><name sortKey="Pang, Kun" sort="Pang, Kun" uniqKey="Pang K" first="Kun" last="Pang">Kun Pang</name></author><author><name sortKey="Shao, Yi" sort="Shao, Yi" uniqKey="Shao Y" first="Yi" last="Shao">Yi Shao</name></author><author><name sortKey="Liang, Sheng Jie" sort="Liang, Sheng Jie" uniqKey="Liang S" first="Sheng-Jie" last="Liang">Sheng-Jie Liang</name></author><author><name sortKey="Cui, Di" sort="Cui, Di" uniqKey="Cui D" first="Di" last="Cui">Di Cui</name></author><author><name sortKey="Zhao, Fu Jun" sort="Zhao, Fu Jun" uniqKey="Zhao F" first="Fu-Jun" last="Zhao">Fu-Jun Zhao</name></author><author><name sortKey="Yu, Jun Jie" sort="Yu, Jun Jie" uniqKey="Yu J" first="Jun-Jie" last="Yu">Jun-Jie Yu</name></author><author><name sortKey="Xia, Shu Jie" sort="Xia, Shu Jie" uniqKey="Xia S" first="Shu-Jie" last="Xia">Shu-Jie Xia</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="doi">10.1007/s10103-013-1437-8</idno><idno type="RBID">pubmed:24026112</idno><idno type="pmid">24026112</idno><idno type="wicri:Area/PubMed/Corpus">000248</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000248</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.</title><author><name sortKey="Wei, Hai Bin" sort="Wei, Hai Bin" uniqKey="Wei H" first="Hai-Bin" last="Wei">Hai-Bin Wei</name><affiliation><nlm:affiliation>Department of Urology, Shanghai First People's Hospital Affiliated to Shanghai Jiaotong University, No.100, Haining Road, Hongkou District, Shanghai, 200080, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhuo, Jian" sort="Zhuo, Jian" uniqKey="Zhuo J" first="Jian" last="Zhuo">Jian Zhuo</name></author><author><name sortKey="Sun, Xiao Wen" sort="Sun, Xiao Wen" uniqKey="Sun X" first="Xiao-Wen" last="Sun">Xiao-Wen Sun</name></author><author><name sortKey="Pang, Kun" sort="Pang, Kun" uniqKey="Pang K" first="Kun" last="Pang">Kun Pang</name></author><author><name sortKey="Shao, Yi" sort="Shao, Yi" uniqKey="Shao Y" first="Yi" last="Shao">Yi Shao</name></author><author><name sortKey="Liang, Sheng Jie" sort="Liang, Sheng Jie" uniqKey="Liang S" first="Sheng-Jie" last="Liang">Sheng-Jie Liang</name></author><author><name sortKey="Cui, Di" sort="Cui, Di" uniqKey="Cui D" first="Di" last="Cui">Di Cui</name></author><author><name sortKey="Zhao, Fu Jun" sort="Zhao, Fu Jun" uniqKey="Zhao F" first="Fu-Jun" last="Zhao">Fu-Jun Zhao</name></author><author><name sortKey="Yu, Jun Jie" sort="Yu, Jun Jie" uniqKey="Yu J" first="Jun-Jie" last="Yu">Jun-Jie Yu</name></author><author><name sortKey="Xia, Shu Jie" sort="Xia, Shu Jie" uniqKey="Xia S" first="Shu-Jie" last="Xia">Shu-Jie Xia</name></author></analytic><series><title level="j">Lasers in medical science</title><idno type="eISSN">1435-604X</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Follow-Up Studies</term><term>Humans</term><term>Laser Therapy (adverse effects)</term><term>Laser Therapy (methods)</term><term>Lasers</term><term>Male</term><term>Postoperative Complications (etiology)</term><term>Postoperative Period</term><term>Preoperative Care</term><term>Prospective Studies</term><term>Prostate (pathology)</term><term>Prostate (surgery)</term><term>Prostatectomy (adverse effects)</term><term>Prostatic Hyperplasia (physiopathology)</term><term>Prostatic Hyperplasia (surgery)</term><term>Thulium (therapeutic use)</term><term>Treatment Outcome</term><term>Urination</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Laser Therapy</term><term>Prostatectomy</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Laser Therapy</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Prostate</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostate</term><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Follow-Up Studies</term><term>Humans</term><term>Lasers</term><term>Male</term><term>Postoperative Period</term><term>Preoperative Care</term><term>Prospective Studies</term><term>Treatment Outcome</term><term>Urination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Thulium laser resection of the prostate-tangerine technique (TmLRP-TT) dissects whole prostatic lobes off the surgical capsule, similar to peeling a tangerine. The present study aimed to evaluate the safety and efficacy of TmLRP-TT for older symptomatic benign prostatic hyperplasia patients with large prostates during 18 months of follow-up. A prospective analysis of 95 consecutive patients with large prostates (>80 ml) who underwent surgical treatment using TmLRP-TT was carried out. All patients were evaluated preoperatively and at 1, 6, 12, and 18 months postoperatively by the International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urinary flow rate (Q max), postvoid residual urine volume (PVR), International Index of Erectile Function 5 (IIEF-5), urine analysis, and urine culture. Perioperative complications were recorded and graded by the modified Clavien classification system (CCS). Mean preoperative prostate volume was 106.81 ± 24.79 ml. TmLRP-TT was successfully completed in all patients. The mean operative duration, catheterization time, and hospital stay were 95.36 ± 27.06 min, 2.25 ± 0.9 days, and 5.39 ± 1.18 days, respectively. The decrease in mean hemoglobin level was 1.23 ± 0.72 g/dl, and that in mean serum sodium level was 0.71 ± 2.56 mmol/l. Within the observation period of 18 months, the patients showed an improvement in IPSS (20.01 ± 7.08 vs. 4.96 ± 3.68), QoL (4.10 ± 1.16 vs. 1.23 ± 1.30), Q max (8.14 ± 3.81 ml/s vs. 18.33 ± 2.56 ml/s) and PVR (102.70 ± 70.64 ml vs. 20.28 ± 30.02 ml), compared with baseline values (P < 0.001). IIEF-5 remained stable. Minor complications occurred in 10 (10.52 %) of 95 patients (Clavien grade 1, 9.47 % and grade 2, 1.05 %). There were no severe complications requiring reintervention (Clavien grade 3, 0 % and grade 4, 0 %). TmLRP-TT is a safe and effective surgical endoscopic technique associated with a low complication rate in large prostates as assessed during an 18-month follow-up period. It is a promising technology, which may be considered as one of the alternatives to open simple prostatectomy (OP) for large prostates in the future.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">24026112</PMID><DateCreated><Year>2014</Year><Month>05</Month><Day>23</Day></DateCreated><DateCompleted><Year>2015</Year><Month>12</Month><Day>15</Day></DateCompleted><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-604X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Lasers in medical science</Title><ISOAbbreviation>Lasers Med Sci</ISOAbbreviation></Journal><ArticleTitle>Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.</ArticleTitle><Pagination><MedlinePgn>957-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10103-013-1437-8</ELocationID><Abstract><AbstractText>Thulium laser resection of the prostate-tangerine technique (TmLRP-TT) dissects whole prostatic lobes off the surgical capsule, similar to peeling a tangerine. The present study aimed to evaluate the safety and efficacy of TmLRP-TT for older symptomatic benign prostatic hyperplasia patients with large prostates during 18 months of follow-up. A prospective analysis of 95 consecutive patients with large prostates (>80 ml) who underwent surgical treatment using TmLRP-TT was carried out. All patients were evaluated preoperatively and at 1, 6, 12, and 18 months postoperatively by the International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urinary flow rate (Q max), postvoid residual urine volume (PVR), International Index of Erectile Function 5 (IIEF-5), urine analysis, and urine culture. Perioperative complications were recorded and graded by the modified Clavien classification system (CCS). Mean preoperative prostate volume was 106.81 ± 24.79 ml. TmLRP-TT was successfully completed in all patients. The mean operative duration, catheterization time, and hospital stay were 95.36 ± 27.06 min, 2.25 ± 0.9 days, and 5.39 ± 1.18 days, respectively. The decrease in mean hemoglobin level was 1.23 ± 0.72 g/dl, and that in mean serum sodium level was 0.71 ± 2.56 mmol/l. Within the observation period of 18 months, the patients showed an improvement in IPSS (20.01 ± 7.08 vs. 4.96 ± 3.68), QoL (4.10 ± 1.16 vs. 1.23 ± 1.30), Q max (8.14 ± 3.81 ml/s vs. 18.33 ± 2.56 ml/s) and PVR (102.70 ± 70.64 ml vs. 20.28 ± 30.02 ml), compared with baseline values (P < 0.001). IIEF-5 remained stable. Minor complications occurred in 10 (10.52 %) of 95 patients (Clavien grade 1, 9.47 % and grade 2, 1.05 %). There were no severe complications requiring reintervention (Clavien grade 3, 0 % and grade 4, 0 %). TmLRP-TT is a safe and effective surgical endoscopic technique associated with a low complication rate in large prostates as assessed during an 18-month follow-up period. It is a promising technology, which may be considered as one of the alternatives to open simple prostatectomy (OP) for large prostates in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Hai-bin</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Urology, Shanghai First People's Hospital Affiliated to Shanghai Jiaotong University, No.100, Haining Road, Hongkou District, Shanghai, 200080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuo</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiao-wen</ForeName><Initials>XW</Initials></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Kun</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Sheng-jie</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Di</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Fu-jun</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jun-jie</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Shu-jie</ForeName><Initials>SJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lasers Med Sci</MedlineTA><NlmUniqueID>8611515</NlmUniqueID><ISSNLinking>0268-8921</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber><NameOfSubstance UI="D013932">Thulium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053685">Laser Therapy</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D007834">Lasers</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011184">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011300">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011467">Prostate</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011468">Prostatectomy</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014554">Urination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="aheadofprint"><Year>2013</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-013-1437-8</ArticleId><ArticleId IdType="pubmed">24026112</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000248 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000248 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24026112
|texte= Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24026112" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |